Facts & figures
BB Biotech
|
|
|
|
|
Foundation |
|
November 9, 1993, Schaffhausen, Switzerland |
|
Issue price adj. 15.11.1993 |
|
CHF 4.75 |
|
Official Listing |
|
Switzerland: December 27, 1993 Germany: December 10, 1997 |
|
Share structure |
|
CHF 11.08 mn nominal, 55 400 000 registered shares with a par value of CHF 0.20 each |
|
Shareholders, free-float as at 30.09.2023 |
|
Institutional and private investors 100% free-float |
|
Security number Switzerland |
|
3 838 999 |
|
Security number Germany |
|
A0NFN3 |
|
ISIN |
|
CH0038389992 |
|
Ticker Bloomberg |
|
Switzerland: BION SW Germany: BBZA GY |
|
Ticker Reuters |
|
Switzerland: BION.S Germany: BION.DE |
|
Type / asset class |
|
Investment company / equity |
|
Investment style |
|
Long only, long term |
|
Index membership |
|
SPI Index |
|
Benchmark |
|
Nasdaq Biotech Index (NBI) TR |
|
Management Fee |
|
All-in-Fee: 1.1% p.a. |
Analyst coverage
|
Institute |
|
Analyst |
|
Baader Helvea |
|
Leonildo Delgado |
|
Edison |
|
Joanne Collins |
|
Kepler Cheuvreux |
|
Nicolas Pauillac |
|
Marten & Co |
|
Matthew Read |
|
Oddo BHF |
|
Oussame Denguir |
|
Pareto Securities |
|
Marietta Miemietz |
|
SEB |
|
Martin Parkhoi |